Ankylosing spondylitis is actually one part of a broader disease spectrum, and for a long time, how doctors defined and diagnosed it left a real gap, one that happened to fall disproportionately on women. Understanding that gap explains a lot about how treatment and research have changed in the last fifteen years.
Looking for treatment options for Ankylosing Spondylitis?
Browse open Ankylosing Spondylitis clinical trials near you! We'll handle the follow-up.
What's approved right now, in plain terms
TNF inhibitors (first approved in 2004, though it was already approved for other conditions like Crohn's disease since 1998) were the first biologics developed for this specific disease, blocking a signaling protein that drives joint inflammation. IL-17 inhibitors came later, secukinumab in 2016 and ixekizumab in 2019, blocking a different inflammatory signal, and are often used when TNF inhibitors don't work well enough or stop working over time.
The diagnostic gap that shaped a generation of research
Ankylosing spondylitis used to be diagnosed mainly by looking for damage on an X-ray of the joints where the spine meets the pelvis. But that damage can take years to show up, even when there's already real inflammation that an MRI can catch. This earlier stage has a name: non-radiographic axial spondyloarthritis. It's now recognized as part of the same disease, just before X-ray changes appear.
Women tend to develop visible X-ray damage more slowly than men, for reasons doctors still don't fully understand. So for years, relying on X-rays alone meant many women were wrongly told they didn't have the disease, simply because it hadn't reached that stage yet. Recognizing non-radiographic axial spondyloarthritis as real and treatable changed that, and today's guidelines cover both stages.
What researchers are studying now
JAK inhibitors, a newer class of oral medicine already used in rheumatoid arthritis, are being studied and increasingly used in ankylosing spondylitis, offering a pill-based option alongside injected biologics. Evidence is still more limited for the non-radiographic, earlier form of the disease specifically, and longer trials are underway to establish how well JAK inhibitors work and how safe they are over years of use, not just months. Other current research looks at whether starting biologic treatment earlier, before X-ray damage develops, changes long-term outcomes compared to waiting for a formal AS diagnosis.
Why ankylosing spondylitis research had to catch up on definitions first
The visibility problem. A disease definition built around X-ray damage inevitably misses people who have the same underlying inflammation without visible damage yet, which is exactly what happened here for years before non-radiographic axial spondyloarthritis was formally recognized.
The sex-gap problem. Because women develop visible X-ray damage more slowly on average, an X-ray-dependent definition systematically underdiagnosed women relative to men, and untangling how much of that gap is biological versus a definition problem is still an active area of research.
The evidence-lag problem. Because non-radiographic axial spondyloarthritis is a newer, more recently recognized category, treatments like JAK inhibitors that already have solid ankylosing spondylitis data don't yet have the same depth of evidence in the non-radiographic form specifically, which is part of why longer trials in that group are still ongoing.
Does ankylosing spondylitis affect more than back pain?
Yes, for many people. Chronic pain and stiffness can affect sleep, mood, and the ability to stay active, which in turn affects overall health over time. If fatigue or low mood are showing up alongside your joint symptoms, that's worth mentioning to your rheumatologist directly rather than assuming it's unrelated or something to just push through.
Common myths, cleared up
"If my X-ray is normal, I don't have ankylosing spondylitis."
A normal X-ray doesn't rule out axial spondyloarthritis, especially early on; MRI can detect inflammation years before X-ray changes appear, and that earlier stage is now recognized as part of the same disease.
"Ankylosing spondylitis is a man's disease."
It's more common in men, but the gap is narrower than historically assumed once non-radiographic axial spondyloarthritis is counted, since women are proportionally more represented in that earlier-stage group.
"Biologics are the only real treatment option."
They're highly effective for many people, but NSAIDs and structured physical therapy remain legitimate first-line approaches, especially early on or for milder disease.
How to find an ankylosing spondylitis study through our platform
Search current studies by whether you've been diagnosed with the X-ray-visible form or the non-radiographic form, since eligibility often depends on that distinction, and by which treatments you've already tried. Right now, for example, one study is refining diagnostic criteria for early axial spondyloarthritis, the exact non-radiographic distinction described above, while another is comparing biosimilar versus original biologic drugs for effectiveness and safety. Our ankylosing spondylitis clinical trials page always shows current recruiting studies. Applying takes about 5 minutes, and a coordinator follows up to confirm fit.
Common questions
Does ankylosing spondylitis qualify as a disability? It can, depending on how severe your symptoms are and how much they limit daily activities. Qualifying for disability benefits involves a separate legal and medical evaluation, so this is worth discussing with your rheumatologist and, if needed, a disability attorney familiar with inflammatory arthritis cases.
Does ankylosing spondylitis affect life expectancy? For most people, ankylosing spondylitis itself doesn't significantly shorten life expectancy, especially with treatment that controls inflammation. Some studies note a modestly increased risk tied to cardiovascular and lung complications in more severe, longstanding cases, which is part of why ongoing monitoring matters.
Does diet make a difference with ankylosing spondylitis? There's no specific diet proven to treat ankylosing spondylitis, though some people report certain foods affect their inflammation or gut symptoms. An anti-inflammatory eating pattern may help overall health, but it isn't a replacement for medical treatment.
Is exercise safe with ankylosing spondylitis? Yes, and it's actually a core part of treatment, not something to avoid. Regular movement and stretching help maintain flexibility and posture, which is part of why physical therapy is recommended alongside medication, not instead of it.
What triggers an ankylosing spondylitis flare? Flares don't always have an obvious trigger, but some people notice patterns tied to stress, poor sleep, or reduced activity. Keeping a symptom diary can help you and your doctor spot your own patterns over time.